EP Patent

EP2534135A2 — Novel forms of ivabradine hydrochloride

Assigned to KRKA dd · Expires 2012-12-19 · 13y expired

What this patent protects

The present invention relates to novel crystalline forms of ivabradine hydrochloride and pharmaceutical compositions prepared therefrom.

USPTO Abstract

The present invention relates to novel crystalline forms of ivabradine hydrochloride and pharmaceutical compositions prepared therefrom.

Drugs covered by this patent

Patent Metadata

Patent number
EP2534135A2
Jurisdiction
EP
Classification
—
Expires
2012-12-19
Drug substance claim
No
Drug product claim
No
Assignee
KRKA dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.